Paper40896702
Resveratrol as a naturally occurring inflammasome modulator: Implications for health and disease.
Ghasemzadeh Rahbardar M and 1 other. Iran J Basic Med Sci, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Resveratrol as a naturally occurring inflammasome modulator: Implications for health and disease. Papers, record 40896702. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40896702
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Resveratrol as a naturally occurring inflammasome modulator: Implications for health and disease.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References149
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24629563 | Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation. | Metabolism | 2014 | https://conductscience.org/library/papers/24629563 | PubMed |
| 2 | 34052324 | Resveratrol for cancer therapy: Challenges and future perspectives. | Cancer Lett | 2021 | https://conductscience.org/library/papers/34052324 | PubMed |
| 3 | 33181351 | The NLRP3 inflammasome triggers sterile neuroinflammation and Alzheimer's disease. | Curr Opin Immunol | 2021 | https://conductscience.org/library/papers/33181351 | PubMed |
| 4 | 36444628 | The role of the NLRP3 inflammasome in chronic inflammation in asthma and chronic obstructive pulmonary disease. | Immun Inflamm Dis | 2022 | https://conductscience.org/library/papers/36444628 | PubMed |
| 5 | 32047476 | The Inflammasome in Reproductive Biology: A Promising Target for Novel Therapies. | Front Endocrinol (Lausanne) | 2020 | https://conductscience.org/library/papers/32047476 | PubMed |
| 6 | 25642707 | Evasion of inflammasome activation by microbial pathogens. | J Clin Invest | 2015 | https://conductscience.org/library/papers/25642707 | PubMed |
| 7 | 37564636 | Salvianolic acid B ameliorates neuroinflammation and neuronal injury via blocking NLRP3 inflammasome and promoting SIRT1 in experimental subarachnoid hemorrhage. | Front Immunol | 2023 | https://conductscience.org/library/papers/37564636 | PubMed |
| 8 | 21889967 | Autoimmune and inflammatory mechanisms of CNS damage. | Prog Neurobiol | 2011 | https://conductscience.org/library/papers/21889967 | PubMed |
| 9 | 29257276 | Resveratrol pretreatment attenuates traumatic brain injury in rats by suppressing NLRP3 inflammasome activation via SIRT1. | Mol Med Rep | 2018 | https://conductscience.org/library/papers/29257276 | PubMed |
| 10 | 32827663 | Resveratrol inhibits tumor progression by down-regulation of NLRP3 in renal cell carcinoma. | J Nutr Biochem | 2020 | https://conductscience.org/library/papers/32827663 | PubMed |
| 11 | 36430976 | Protein Misfolding and Aggregation in the Brain: Common Pathogenetic Pathways in Neurodegenerative and Mental Disorders. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36430976 | PubMed |
| 12 | 27566199 | Effect of alcoholic extract of aerial parts of Rosmarinus officinalis L. on pain, inflammation and apoptosis induced by chronic constriction injury (CCI) model of neuropathic pain in rats. | J Ethnopharmacol | 2016 | https://conductscience.org/library/papers/27566199 | PubMed |
| 13 | 26464617 | Resveratrol pretreatment protects rat hearts from ischemia/reperfusion injury partly via a NALP3 inflammasome pathway. | Int J Clin Exp Pathol | 2015 | https://conductscience.org/library/papers/26464617 | PubMed |
| 14 | 22258606 | Inflammasomes in health and disease. | Nature | 2012 | https://conductscience.org/library/papers/22258606 | PubMed |
| 15 | 25687021 | Anti-inflammatory effect of resveratrol in old mice liver. | Exp Gerontol | 2015 | https://conductscience.org/library/papers/25687021 | PubMed |
| 16 | 34303665 | Effect of resveratrol on inflammatory cytokines: A meta-analysis of randomized controlled trials. | Eur J Pharmacol | 2021 | https://conductscience.org/library/papers/34303665 | PubMed |
| 17 | 32147075 | Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial. | Complement Ther Med | 2020 | https://conductscience.org/library/papers/32147075 | PubMed |
| 18 | 28989978 | The therapeutic potential of resveratrol: a review of clinical trials. | NPJ Precis Oncol | 2017 | https://conductscience.org/library/papers/28989978 | PubMed |
| 19 | 32751625 | Innate Immune Response to Tick-Borne Pathogens: Cellular and Molecular Mechanisms Induced in the Hosts. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32751625 | PubMed |
| 20 | 35492620 | Editorial: Mechanisms of Inflammation and Fibrosis Interplays in the Digestive Diseases. | Front Physiol | 2022 | https://conductscience.org/library/papers/35492620 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42890382 | Resveratrol as an immune checkpoint inhibitor to enhance the efficacy of breast cancer immunotherapy. | Iran J Basic Med Sci | 2026 | https://conductscience.org/library/papers/42890382 | PubMed |
| 42885307 | Resveratrol alleviates osteoarthritis progression by inhibiting NLRP3 inflammasome response via the AMPK/PPARγ signaling pathway. | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42885307 | PubMed |
| 42405401 | Resveratrol and the NLRP3 Inflammasome: Unlocking the Anti-inflammatory Potential of a Natural Compound. | Curr Pharm Des | 2026 | https://conductscience.org/library/papers/42405401 | PubMed |
| 42356251 | Resveratrol-Enriched Polygonum cuspidatum Extract Enhances Functional Bioactivity Against Non-Small Cell Lung Cancer Through Modulation of Inflammatory Signaling and Mitochondrial Apoptosis. | Nutrients | 2026 | https://conductscience.org/library/papers/42356251 | PubMed |
| 41661106 | Post-TB lung disease: pathogenesis, host-directed therapies, and the C3HeB/FeJ model for pre-clinical advances. | Infect Immun | 2026 | https://conductscience.org/library/papers/41661106 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40896702
GET https://conductscience.org/api/papers/v1/40896702/references?page=2